Albemarle Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALB research report →
Range $130 – $250
Price Chart
About the company
Albemarle Corporation stands as a global innovator, producing and distributing a diverse portfolio of engineered specialty chemicals. Its business operations are divided into three principal segments: Lithium, Bromine, and Catalysts. The Lithium division supplies a variety of lithium compounds, including lithium carbonate, hydroxide, and chloride, alongside critical reagents like butyllithium.
- CEO
- Jerry Kent Jr.
- IPO
- 1994
- Employees
- 7,800
- HQ
- Charlotte, NC, US
AI snapshot
Six angles, distilled from the data.
ALB is still in a long-term downtrend, trading well below its 200-day average of 155.8 after a sharp reset from the 52-week high near 219.7. The stock has stabilized above the 52-week low of 84.9, but the regime remains corrective rather than trending higher.
Street sentiment is constructive but cautious: consensus sits at Buy, with 20 Buy, 20 Hold, and 5 Sell ratings. The average target is 194.56, but recent target cuts from Mizuho, Morgan Stanley, Scotiabank, UBS, and RBC show expectations have been drifting lower.
The next print carries a favorable beat backdrop after ALB topped EPS estimates in 5 of the last 7 quarters, including 11.9% and 125.2% beats in the two most recent reported periods. Analysts still look for a sharp earnings rebound, with next-year EPS estimated at 11.2973 versus TTM EPS of 0.26.
No notable discretionary insider buying or selling. Recent activity is dominated by award grants and in-kind vesting-related transactions for officers and directors, which reads as routine compensation rather than a conviction signal.
Profitability is mixed but improving at the operating line: operating margin is 27.71% and gross margin is 24.0%, while net margin remains thin at 3.8%. Growth is strong on revenue, up 31.1% year over year, and free cash flow was 1.872 billion with a 15.0% FCF yield.
ALB’s lithium and specialty-chemicals exposure gives it more torque than diversified chemical peers, but also more cycle risk. At 17.56x earnings, it trades at a moderate multiple for the sector, below the market’s usual premium for cleaner growth visibility.
Similar companies
Peers in the same neighborhood.
- Market Cap
- $12.31B
- P/E
- 217.44
- Fwd P/E
- 9.09
- PEG
- -0.22
- P/S
- 2.08
- P/B
- 1.20
- EV/EBITDA
- 10.29
- Div Yield
- 1.56%
- Gross Margin
- 23.89%
- Op Margin
- 11.92%
- Net Margin
- 3.79%
- ROE
- 2.26%
- ROIC
- 3.34%
Latest fiscal year · YoY change
- Revenue
- $5.14B-4.4%
- Gross Profit
- $671.62M+1014.9%
- Op Income
- $93.79M
- Net Income
- $-510,628,000+56.7%
- EPS
- $-5.75+48.7%
- OCF Growth
- +86.4%
- FCF Growth
- +169.8%
- 52W High
- $221.00
- 52W Low
- $88.01
- 50D MA
- $122.63
- 200D MA
- $155.22
- Beta
- 1.33
- RSI (14)
- 33
- Avg Volume
- 2.28M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Albemarle delivered a sharply stronger Q2 on lithium pricing and cost discipline, while lifting specialties outlook and highlighting tight lithium markets and improved cash generation.· August 6, 2026
- Q2 net sales were $1.7 billion, up 31% year over year; adjusted EBITDA was $858 million, up 155%, and diluted EPS was $3.52.
- Enterprise EBITDA margin expanded to 49%; cash from operations was $710 million and free cash flow was $638 million.
- Specialties was the standout on both pricing and volume, and management raised full-year Specialties sales to $1.4 billion-$1.6 billion and adjusted EBITDA to $275 million-$325 million.
- Energy storage demand remained very strong, but Q3 is expected to be weaker sequentially due to lower volumes, lower pricing assumptions, and the Greenbushes CGP3 fire impact.
- Management raised its stationary storage demand outlook for 2026 and 2030 and said lithium inventories remain near record lows, keeping the physical market tight.
Second-quarter net sales were $1.7 billion, up 31% year over year. Adjusted EBITDA was $858 million, up 155% year over year, net income attributable to Albemarle was $480 million, and diluted EPS was $3.52. Enterprise EBITDA margin expanded to 49%, cash from operations was $710 million, and free cash flow was $638 million. In Specialties, net sales were $424 million, up 20% year over year, and adjusted EBITDA was $118 million, up 61%, with a 28% margin. In Energy Storage, net sales increased 78% year over year and adjusted EBITDA increased 229%; volume was 65,000 tons LCE and average realized price was about $20 per kilogram LCE. For the full year, Energy Storage volumes are now expected to be 225,000 to 235,000 tons LCE, or flat to down 4% year over year, and Specialties full-year outlook was raised to $1.4 billion-$1.6 billion of net sales and $275 million-$325 million of adjusted EBITDA. Management said the company remains on track to reach the high end of its $100 million to $150 million cost and productivity target, while full-year cash flow will still be affected by $87.5 million of deferred revenue and about $100 million of spend related to idling Kemerton Train 1.
Kent Masters said the quarter reflected disciplined execution, operational excellence and resilient end markets, with demand for lithium and storage staying exceptionally strong. He emphasized that inventory levels are low, the physical lithium market remains tight, and Albemarle is improving its 2026 outlook while also advancing longer-term growth options such as DLE at the Salar de Atacama and brownfield opportunities in Australia. His tone was confident and constructive, with repeated emphasis on disciplined capital allocation and durable competitive advantages.
Neal Sheorey focused on the numbers and the mechanics behind them: higher lithium pricing, stronger Specialty pricing and volumes, and cost/productivity improvements drove the EBITDA outperformance. He noted roughly $100 million of run-rate savings year to date, putting the company on track to hit the high end of the $100 million to $150 million annual target, and reiterated that the company is maintaining total-company outlook ranges while expecting to land near the top end. He also said first-half operating cash flow conversion is at the high end of the long-term 60% to 70% target, while full-year cash flow will be affected by $87.5 million of deferred revenue and about $100 million of Kemerton Train 1 idling spend.
Analysts pressed management on what “top end” guidance meant, lithium supply and pricing durability, and whether stationary storage demand revisions reflect real customer pull or a conservative initial forecast. Management said the top-end comment applies to both the total company and Energy Storage, and explained that stronger-than-expected grid-storage demand, especially in China, made the initial outlook too cautious. On supply, management said Africa and lepidolite restarts are helping but not enough to offset demand growth, while on Specialties they said the China bromine index is only one part of a broader, more diversified business and that pricing normalization in the back half of the year is assumed but remains fluid given the Middle East situation.
The bull case from this call is that Albemarle is benefiting from a powerful combination of stronger lithium demand, tight inventories, and pricing that remains supportive even after recent moves. The company also showed meaningful operating leverage and cash conversion, while raising its Specialties outlook and reaffirming confidence in longer-term growth via stationary storage, brownfield expansion, and DLE.
The main risks are that Energy Storage volumes and margins are expected to fall sequentially in Q3, CGP3’s restart has pushed the full ramp into 2027, and the Middle East-related supply-chain disruption is still unresolved. Management also acknowledged that bromine pricing has likely peaked and could normalize, while lithium pricing is highly speculative and driven by trading and coming supply restarts.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.7%
- Shares Outstanding
- 117.93M
- Float Shares
- 117.54M
of shares held by institutions
1,049 13F filers
Congressional trading
Senate and House stock disclosures for ALB, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| John BoozmanSenate · AR | Buy | May 15, 26 | Filing → |
| Jefferson ShreveHouse · IN06 | Sell | May 12, 25 | Filing → |
| Jefferson ShreveHouse · IN06 | Buy | Apr 7, 25 | Filing → |
| Julie JohnsonHouse · TX32 | Sell | Feb 12, 25 | Filing → |
| Jefferson ShreveHouse · IN06 | Sell | Feb 24, 25 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Sep 9, 24 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Sep 9, 24 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Sep 9, 24 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Feb 13, 24 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Feb 13, 24 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Oct 31, 23 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Oct 2, 23 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Aug 3, 23 | Filing → |
| Rick W. AllenHouse · GA12 | Buy | Feb 10, 21 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 14.53M | ▼ 74.50K |
| Capital World Investors | 9.90M | ▲ 66.46K |
| Blackrock, Inc. | 9.50M | ▲ 766.75K |
| Vanguard Capital Management LLC | 7.70M | ▲ 40.80K |
| Vanguard Portfolio Management LLC | 6.44M | ▲ 121.55K |
| State Street Corp | 5.50M | ▲ 275.68K |
| Barclays PLC | 3.30M | ▲ 2.06M |
| Geode Capital Management, LLC | 3.13M | ▼ 304.05K |
| Morgan Stanley | 2.90M | ▲ 648.00K |
| Fmr LLC | 2.69M | ▲ 2.45M |
| Primecap Management Co | 2.65M | ▼ 12.70K |
| Bank Of America Corp | 2.54M | ▼ 433.01K |
Held by 1,086 ETFs
Biggest fund positions in ALB by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 1, 26 | Wolff Alejandro Daniel | other | 45 |
| Sep 14, 26 | Norris Eric | other | 10,867 |
| Sep 14, 26 | Mummert Mark Richard | other | 6,086 |
| Sep 14, 26 | Gagarinas Autumn M. | other | 5,217 |
| Sep 1, 26 | Hood Max | other | 1,476 |
| Aug 24, 26 | Hood Max | other | 0 |
| Jul 21, 26 | DESALLES BARTOLOMEO EDUARDO | other | 1,375 |
| Jul 21, 26 | DESALLES BARTOLOMEO EDUARDO | other | 0 |
| Jul 1, 26 | MINOR GLENDA J | other | 1,250 |
| Jul 1, 26 | Collins Michelle T | other | 2 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ALB coverage
Recent articles, reports, and earnings notes.

Best Specialty Chemicals Stocks for August 2026
Seven specialty chemicals stocks ranked by investment quality, with a countdown spanning additives, engineered materials, electronics, energy storage, and process chemicals.

Super Startup, Revealed: Every Stock Adam O’Dell Is Teasing in Green Zone Fortunes
Adam O’Dell of Green Zone Fortunes and Money & Markets is pitching the “Super Startup” and Megablock Wealth Blueprint. We trace the Tesla-energy claims and identify the companies behind them.

America's New Power Grid, Revealed: Every Stock Adam O'Dell Is Teasing in Green Zone Fortunes
Adam O'Dell's Money & Markets report America's Secret Vault Revealed pitches “America's New Power Grid”; we trace the companies behind it and test the claims.
Want a deeper read on ALB?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Albemarle: Fundamentals Improve On All Fronts
seekingalpha.com · Oct 2
Albemarle Corporation to Release Third Quarter 2026 Earnings Results on Wednesday, November 4, 2026
prnewswire.com · Oct 1
Albemarle (ALB) Registers a Bigger Fall Than the Market: Important Facts to Note
zacks.com · Sep 30
Is Trending Stock Albemarle Corporation (ALB) a Buy Now?
zacks.com · Sep 30
Albemarle vs. Rio Tinto: Which Lithium Stock Holds More Promise?
zacks.com · Sep 29
Contrasting FUCHS (OTCMKTS:FUPBY) and Albemarle (NYSE:ALB)
defenseworld.net · Sep 28
Albemarle (ALB) Falls More Steeply Than Broader Market: What Investors Need to Know
zacks.com · Sep 24
Wall Street Bulls Look Optimistic About Albemarle (ALB): Should You Buy?
zacks.com · Sep 21
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
AI analysis · Last refreshed October 2, 2026 · Live quote · Not investment advice